9Fisk NM, Ronderos Dumit D, Soliani A, et al. Diagnostic and therapeutic transabdominal amnioinfusion in oligohydramnios [J].Obstet Gynecol, 1991,78:270-278.
10Joseph VT. The managemet of renal conditions in the Perinatal Period [ J ]. Early Hum Dev, 2006,82 ( 5 ) : 313 -324.
4ROSSI AC, PREFUMO F. Perinatal outcomes of isolated oligohy- dramnios at term and post-term pregnancy: a systematic review of literature with meta-analysis[J]. Eur J Obstet Gynecol Reprod Biol, 2013, 169(2): 149-154.
5ABRAHAM RJ. The protective effect of oligohydramnios in a case of missed diagnosis of spontaneous septostomy in mono- chorionic diamniotic twins[J]. J Obstet Gynaecol, 2013, 33(2): 205-207.
6SEIB FP, HERKLOTZ M, BURKE KA, et al. Muhifunctional silk-heparin biomaterials for vascular tissue engineering applica- tions[J]. Biomaterials, 2014, 35(1): 83-91.
7ANDRAE J, EHRENCRONA H, GALLINI R, et al. Analysis of mice lacking the heparin-binding splice isoform of platelet-de- rived growth factor A[J]. Mol Cell Bid, 2013, 33(20): 4030-4040.
8NORRBY K, NORDENHEM A. Dalteparin, a low-molecu- lar-weight heparin, promotes angiogenesis mediated by hep- arin-binding VEGF-A in vivo[J]. APMIS, 2010, 118(12): 949- 957.
9BLOOR M, PAECH M. Nonsteroidal anti-inflammatory drugs during pregnancy and the initiation of lactation [J]. Anesth Analg, 2013, 116(5): 1063-1075.
10HRON G, KNUTSON F, THIELE T, et al. Alternative diagnosis to heparin-indueed thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody test[J]. Ups J Med Sci, 2013, 118(4): 279-284.
